US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

MRKR Marker Therapeutics Inc

4.00

0.13 (3.36%)

Última actualización: 09:54:51

Retrasado por 15 minutos

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
tm2313732d2_ars.pdf

Marker Therapeutics (NASDAQ:MRKR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Marker Therapeutics.

Marker Therapeutics (NASDAQ:MRKR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Marker Therapeutics.

Noticias sobre Marker Therapeutics, Inc. MRKR

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Viernes 17 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Miércoles 15 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Miércoles 15 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
Lunes 8 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
Lunes 25 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Viernes 22 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Viernes 1 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 26 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601
Lunes 22 de Enero 2024 (4 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Lunes 8 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization
Lunes 8 de Enero 2024 (5 meses hace) • GlobeNewswire Inc.

Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”
Jueves 21 de Diciembre 2023 (5 meses hace) • GlobeNewswire Inc.

Más de Marker Therapeutics, Inc. Artículos de Noticias

JP Morgan Chase

Bank of America

US Dollar vs MXN

BNP Paribas (QX)

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones